In this issue:
DOAC regimens in AF patients with high bleeding risk
An evidence-based screening tool for HFpEF
Impact of early rhythm control and healthy lifestyle in patients with AF
Complete vs culprit-only revascularisation in older patients with MI and high bleeding risk
Cardiovascular benefits of semaglutide in overweight or obese patients without diabetes
Cardiovascular benefits of bempedoic acid vs statins
Catheter ablation as first-line therapy for persistent AF
Acute cardiac events in older adults hospitalised with RSV infection
Lipoprotein(a) levels and long-term plaque progression
Aspirin for secondary prevention of ASCVD in males vs females
Please login below to download this issue (PDF)